Ketamine for Nerve Pain (Neuropathic Pain) and What the Research Shows

Some mornings, the burning down your leg makes the first ten minutes of standing feel impossible. A cotton t-shirt against your skin hurts even though it should feel harmless. You've tried gabapentin, maybe duloxetine (Cymbalta), maybe a lidocaine patch. And the relief, when it comes, never quite holds.

You've tried a lot, and that cycle of hoping and watching the relief fade gets exhausting. About 1 in 4 US adults live with chronic pain, and for nerve pain especially, finding something that works is its own long process.

The short answer: ketamine may help reduce nerve pain intensity, usually as a later-line option after standard treatments haven't been enough. Ketamine isn't FDA-approved for nerve pain, so using it this way is off-label and belongs in clinician-guided care. The research behind it is real but still limited, and results vary by individual.

What Neuropathic Pain Actually Is

Most pain is your body doing its job: you touch a hot stove, the nerve fires, you pull your hand back. Neuropathic pain is different. The International Association for the Study of Pain describes it as pain caused by damage or disease affecting the sensory nervous system. In plainer terms, the pain-signaling system itself has malfunctioned, and the pain can keep going even when there's no ongoing tissue damage.

That's why neuropathic pain produces sensations that don't match anything happening to your body. Common experiences include:

• Allodynia: pain from something that shouldn't hurt at all, like a light touch or brushing your hair.
• Hyperalgesia: an outsized, exaggerated response to something only mildly painful.
• Spontaneous pain: burning, stabbing, or electric-shock sensations that show up with no trigger.

The conditions behind it

Diabetic neuropathy causes burning and electric pain in the feet and legs; postherpetic neuralgia lingers after shingles; complex regional pain syndrome (CRPS) can follow an injury and refuse to leave. Overall, neuropathic pain affects roughly 7 to 10% of adults, and among people already living with chronic pain, 30 to 40% have a neuropathic component.

It rarely travels alone. Sleep disruption affects 50 to 80% of people with chronic pain, and depression and anxiety are common companions. That overlap matters, because pain and sleep run on a two-way street: ease one and the other often follows.

How Ketamine Works for Nerve Pain

When pain signals fire over and over, the nervous system can get easier and easier to set off. Pain gets amplified, minor sensations start to feel excruciating, and pain can fire with no trigger at all. This is called central sensitization. A key player in it is the NMDA receptor, part of the nervous system's pain-signaling machinery.

Prolonged pain signaling ramps these receptors up at spinal-cord connections, which turns up the volume along the body's pain pathways.

Ketamine's main target is that NMDA receptor. By blocking NMDA receptors when the pathway is overactive, it interrupts part of the pain-amplifying process. That's what sets ketamine apart from medications you may already have tried, like gabapentinoids and antidepressants such as duloxetine or tricyclics, which work on other pathways.

The goal is to turn down the volume on pain signaling so that sleep, movement, and the rest of your day have more room. Whether it does that for any one person depends on a lot, and response is uneven.

What the Research Actually Shows

The largest meta-analysis pooled 18 randomized trials and 706 participants. A week after treatment, average pain dropped by about 2 points on a 10-point scale; at 30 days, by closer to 1.7 points. Those improvements are real but modest, and the reviewers rated the overall evidence quality low because the studies varied so much in dosing, delivery, and who was treated.

Relief also tends to outlast the session: a single treatment often helps for days to a couple of weeks, sometimes longer.

Where the evidence is strongest, and weakest

The strongest signal is in complex regional pain syndrome (CRPS), where pooled data point to meaningful short-term relief for many people, but with high variability and effects that tend to fade. The picture is weaker for function: several trials found pain dropping without a clear gain in mobility or daily activity, and one placebo-controlled CRPS study saw the relief fade by week 12.

The most cautious read comes from Cochrane reviewers, whose 2025 review across dozens of trials found no clear evidence of benefit for ketamine in chronic pain, with low-to-very-low certainty. Even so, other randomized trials still point to modest short-term reductions, and the reviewers were careful to say the data could reflect a real benefit or none at all.

So ketamine is mechanistically distinct and genuinely promising, but with modest effects, thin long-term data, and uneven individual responses. For most people living with chronic pain, that places it later in the lineup than the first things you've likely tried.

Where Ketamine Fits and Who It's For

Ketamine comes later in the treatment sequence. Standard care for nerve pain usually starts with first-line medications, antidepressants like tricyclics or SNRIs such as duloxetine plus gabapentinoids, then moves to options like lidocaine or capsaicin patches. Ketamine enters the conversation after those approaches haven't delivered.

That later-line position reflects a hard reality: fewer than half of people get satisfactory relief from the neuropathic pain treatments available today. If you've cycled through several without lasting improvement, you've done the trying; standard care simply hasn't kept up. The toll that takes on sleep and mood is part of the hidden impact chronic pain has on daily life.

Who it's not right for

Ketamine isn't right for everyone. It may be a poor fit for people with a history of psychosis, certain serious heart conditions, uncontrolled high blood pressure, or pregnancy, among others. Side effects during treatment, including dissociation, dizziness, and sometimes nausea, usually settle within hours.

The FDA has also flagged bladder and urinary risks, with the severe forms largely tied to frequent or high-dose use. Careful screening is exactly why this is clinician-guided care rather than something to try on your own, and it's a big part of ketamine safety.

If you're taking opioids

If you're currently taking opioids, ketamine may be relevant as part of a broader plan. Some people are able to reduce their reliance on opioids over time with clinical guidance, partly because ketamine can counteract opioid-induced hyperalgesia, the heightened pain sensitivity that long-term opioid use sometimes causes.

Reducing opioid use is a decision you make together with your prescriber, never on your own. If opioid concerns are part of why you're here, Innerwell's clinicians can talk it through with you as part of your care.

How the At-Home Approach Compares to Infusions

Almost everything written about ketamine for nerve pain describes IV infusions in a clinic, so it's worth being clear about how an at-home oral program differs.

The strongest research is on IV infusions, and the evidence for oral ketamine is thinner. What an at-home program trades for that is access and structure: care you can actually keep up with, and monitoring that continues between doses instead of ending when you leave the suite.

A third option is worth naming too: app-based or behavioral-only pain programs. Those can help with pacing and coping, but they don't include a prescribed medication.

A program like Innerwell's pairs the medication with that kind of ongoing support. Which approach fits depends on your situation: if repeated clinic visits are part of what makes treatment hard, the at-home model removes that barrier; if you'd only consider the most heavily studied route, in-clinic infusions are worth raising with a pain specialist.

How Innerwell's Pain Program Works

By the time you're reading about ketamine, the practical question is usually simple: what would actually doing this look like?

Chronic pain is both a physical signal and the way your nervous system has learned to process pain over time. Ketamine may help quiet that signaling, but the medication is only part of the work. What dose fits you and whether a response holds vary from person to person, so the value comes from tracking how you actually respond over weeks and adjusting from there.

That ongoing adjustment is the difference between a structured plan and just hoping the next dose lands better than the last.

What the program looks like

This isn't a one-time infusion. It's a structured 12-week program built for chronic pain and delivered at home.

The program: You start with a short online screener, then a video consult and lab review with a licensed clinician who specializes in pain. They review your pain history, what you've already tried, your current medications (including opioids), and your safety factors. If you're medically approved, oral ketamine tablets are shipped to your home, with no clinic visits required, and your clinician adjusts dosing across the program based on how you're actually doing.

Here's what makes the program different:

• Pain-specialized clinicians. Licensed clinicians who review your full history before any treatment is approved, then tune dosing and frequency to your response (pain intensity, function, side effects).
• Support for what travels with pain. Regular check-ins, a patient portal, psychiatric consults, and in-app tools for the depression, anxiety, or sleep trouble that often come with chronic pain.
• Access. Insurance coverage mirrors Innerwell's ketamine program where available, with self-pay and HSA/FSA options. Coverage varies by state and plan; the medical consult fee is non-refundable, and monthly charges apply only after medical approval.

Who it's for

The program supports adults with moderate to severe chronic pain who are medically approved by an Innerwell clinician, including nerve pain and neuropathy, back and joint pain, fibromyalgia, chronic post-surgical pain, autoimmune-related pain, and chronic musculoskeletal pain. Because ketamine isn't FDA-approved for pain, this use is off-label and always clinician-supervised.

The focus stays on function: sleep, mobility, and getting more of your day back. Many people report improvement in pain intensity and daily function within the first month, though results vary by individual and ketamine isn't right for everyone.

If standard treatments haven't given you enough, the next step is simply to see whether this is a good fit.

See if you're eligible for Innerwell's structured pain management program.

Frequently Asked Questions

Am I a candidate for ketamine for neuropathic pain?

Ketamine is generally considered for people whose nerve pain hasn't responded well to first- and second-line treatments like gabapentinoids, SNRIs, or topical patches. It isn't appropriate for everyone, and a handful of medical factors can rule it out. The only real way to know is an evaluation that looks at your history and screens for safety, which is exactly what Innerwell's screening is built to do. Not everyone responds the same way.

Can I still take my other pain medications?

Often, yes, though your clinician reviews it with you first. At Innerwell, a clinician looks at everything you're currently taking before any treatment is approved, and ketamine is usually added to a broader plan rather than swapped in for what you're on. If you're taking opioids, some people are able to reduce their reliance over time with clinical guidance, but that's a decision you make together with your prescriber, never on your own.

Will ketamine work for my diabetic neuropathy or CRPS?

Pooled CRPS research points to meaningful short-term relief for many people. For diabetic neuropathy and other peripheral neuropathic conditions, the evidence is more limited and less certain. Ketamine may help reduce pain intensity in these conditions, but results vary by individual. Whether it's a fit for you comes down to your specific history and safety factors, which an Innerwell clinician reviews before any treatment begins.